Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
This guide highlights the widely used indices in finance and explains their role in benchmarking, analysis, and portfolio decisions.
23,671 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Tesla stock slides as delivery fears collide with SpaceX IPO chatter and a Cybercab roadmap, leaving investors weighi...
A $225 million merger unites Major League Pickleball with Carvana's PPA Tour, forming Pickleball Inc. and signaling a...
Strategy, the software firm formerly known as MicroStrategy, reported a $12.77 billion first-quarter loss as Bitcoin ...
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
A notable stake in TowneBank marks a strategic bet by Patriot Financial Partners. This article breaks down what the i...
Geopolitical tensions push fuel costs higher, prompting DoorDash to fund more than $50 million in gas-price relief fo...
Pattern PTRN just released its Q1 2026 earnings, revealing growth drivers and fresh guidance. This analysis breaks do...
This article dives into EverCommerce (evcm) 2026 earnings, unpacking Q1 results, growth drivers, and the implications...
A luxury baby blanket priced at $1,375 has become a symbol of how motherhood in America comes with outsize costs. Thi...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
XRP flashed a fresh TD Sequential buy signal on the 4-hour chart, renewing bets on a sharp advance as traders eye key...